ETF Managers Group, LLC Evaxion Biotech A/S Transaction History

ETF Managers Group, LLC

  • $2.78 Billion
  • Q1 2023

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.6 - $3.07 $11,232 - $21,551
-7,020 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$2.66 - $4.65 $53 - $93
20 Added 0.29%
7,020 $22,000
Q4 2021

Feb 14, 2022
BUY
$4.0 - $12.68 $564 - $1,787
141 Added 2.06%
7,000 $31,000
Q3 2021

Nov 15, 2021
BUY
$5.32 - $9.65 $6,368 - $11,551
1,197 Added 21.14%
6,859 $64,000
Q2 2021

Aug 16, 2021
SELL
$5.2 - $7.94 $1,331 - $2,032
-256 Reduced 4.33%
5,662 $43,000
Q1 2021

May 17, 2021
BUY
$5.3 - $9.95 $31,365 - $58,884
5,918 New
5,918 $31,000

Others Institutions Holding EVAX

# of Institutions
1
Shares Held
37.5K
Call Options Held
0
Put Options Held
0
View Full List

About Evaxion Biotech A/S

EVAX Quotes by TradingView
  • Ticker EVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,977,900
  • Market Cap $71.2M
  • Description
  • Evaxion Biotech A/S, a clinical-stage biotech company, engages in developing artificial intelligence-powered immunotherapies for cancers, bacterial diseases, and viral infections. The company develops EVX-01, a cancer immunotherapy that is in clinical Phase IIb trial for metastatic melanoma; EVX-02, a DNA-based cancer immunotherapy that is in Ph...
More about EVAX
Track This Portfolio

Track ETF Managers Group, LLC Portfolio

Follow ETF Managers Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on ETF Managers Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email